A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...

An EMR-based alert helped reduce unnecessary orders for testing for Clostridioides difficile infection in hospitals, according to a study published in Infection Control & Hospital Epidemiology.

Most laboratories have begun using polymerase chain reaction assays, or the PCR technique, as opposed to enzyme-linked immunosorbent assay detection, also known as ELISA testing, to diagnose ...

Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...

Please provide your email address to receive an email when new articles are posted on . Newly released practice guidelines for Clostridium difficile infection, or CDI, in both adults and children ...

Please provide your email address to receive an email when new articles are posted on . Two-step testing was associated with a decrease in hospital-onset C. difficile infection. Similar decreases were ...

A new study published today in the American Journal of Infection Control (AJIC) suggests that allowing bedside nurses to independently order testing for C. difficile significantly decreased the amount ...

SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...

Dogs have previously shown promise in sniffing out bacterial infections, but a new Canadian study is walking those assertions back. Investigators with the Michael Garron Hospital were recently the ...

MedCity News’ Brandon Glenn breaks down the recent FDA approval of Meridian Bioscience’s pediatric version of its C. difficile test on this week’s edition of Health Journal on ONN. Meridian said its ...

Great Basin Corp. has announced it has received FDA 510(k) clearance for its molecular diagnostic test for Clostridium difficile, according to a news release (pdf). “Workflow matters, especially when ...

CINCINNATI, Ohio — Meridian Bioscience Inc. reported record revenue and net income for its fiscal first quarter, despite increased competition for sales of C. difficile test kits. The Cincinnati ...